Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
Why this paper is included
Supporting source evidence:
We found that dementia incidence was associated with low vitamin D concentration (hazard ratio 0.994, 95% confidence interval 0.993 to 0.996), indicators of endocrine disorders: IGF-1 level (P for non-linearity = 1.1E-05), testosterone level (P for non-linearity = 0.006); high sex-hormone-binding globulin level (HR 1.004, 95% CI: 1.003 to 1.006); reduced liver function: lower alanine aminotransferase (HR 0.990, 95% CI: 0.986 to 0.995); renal dysfunction: cystatin C level (P for non-linearity = 0.028); oxidative stress: lower urate level (HR 0.998, 95% CI: 0.998 to 0.999); lipids dysregulation: lower LDL (HR 0.918, 95% CI: 0.872 to 0.965) and triglycerides (HR 0.924, 95% CI: 0.882 to 0.967) concentrations; insulin resistance: high glucose (HR 1.093, 95% CI: 1.045 to 1.143) and HbA1c (HR 1.017, 95% CI: 1.009 to 1.025) levels; immune dysbiosis: C−reactive protein (P for non-linearity = 5.5E-09).
Source: Abstract. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Cohort study.
Cohort study
Examines exposures and outcomes over time within a defined group.
Meta-analysis unclear · Blinding unclear / not reported · Human research reported
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
Serum clinical laboratory tests and risk of incident dementia: a prospective cohort study of 407,190 individuals
Source: Article title.
70,647 participants were excluded due to already having a dementia diagnosis at baseline or without follow-up.
Source: Methods.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
Serum clinical laboratory tests and risk of incident dementia: a prospective cohort study of 407,190 individuals
Cohort study · Translational Psychiatry · 2022
Original publication title
Serum clinical laboratory tests and risk of incident dementia: a prospective cohort study of 407,190 individuals
© The Author(s) 2022
Original publication · Publisher record · CC BY 4.0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
What does the authors’ abstract report?
Prevention of dementia is a public health priority, and the identification of potential biomarkers may provide benefits for early detection and prevention. This study investigates the association of common serum laboratory tests with the risk of incident dementia. Among 407,190 participants from the UK Biobank (median follow-up of 9.19 years), we investigated the linear and nonlinear effects of 30 laboratory measures on the risk of all-cause dementia using Cox models and restricted cubic spline models. We found that dementia incidence was associated with low vitamin D concentration (hazard ratio 0.994, 95% confidence interval 0.993 to 0.996), indicators of endocrine disorders: IGF-1 level (P for non-linearity = 1.1E-05), testosterone level (P for non-linearity = 0.006); high sex-hormone-binding globulin level (HR 1.004, 95% CI: 1.003 to 1.006); reduced liver function: lower alanine aminotransferase (HR 0.990, 95% CI: 0.986 to 0.995); renal dysfunction: cystatin C level (P for non-linearity = 0.028); oxidative stress: lower urate level (HR 0.998, 95% CI: 0.998 to 0.999); lipids dysregulation: lower LDL (HR 0.918, 95% CI: 0.872 to 0.965) and triglycerides (HR 0.924, 95% CI: 0.882 to 0.967) concentrations; insulin resistance: high glucose (HR 1.093, 95% CI: 1.045 to 1.143) and HbA1c (HR 1.017, 95% CI: 1.009 to 1.025) levels; immune dysbiosis: C−reactive protein (P for non-linearity = 5.5E-09).
In conclusion, markers of vitamin D deficiency, GH-IGF-1 axis disorders, bioactive sex hormone deficiency, reduced liver function, renal abnormalities, oxidation, insulin resistance, immune dysbiosis, and lipids dysregulation were associated with incident dementia. Our results support a contributory role of systemic disorders and diverse biological processes to onset of dementia.
Authors’ abstract
Prevention of dementia is a public health priority, and the identification of potential biomarkers may provide benefits for early detection and prevention. This study investigates the association of common serum laboratory tests with the risk of incident dementia. Among 407,190 participants from the UK Biobank (median follow-up of 9.19 years), we investigated the linear and nonlinear effects of 30 laboratory measures on the risk of all-cause dementia using Cox models and restricted cubic spline models. We found that dementia incidence was associated with low vitamin D concentration (hazard ratio 0.994, 95% confidence interval 0.993 to 0.996), indicators of endocrine disorders: IGF-1 level (P for non-linearity = 1.1E-05), testosterone level (P for non-linearity = 0.006); high sex-hormone-binding globulin level (HR 1.004, 95% CI: 1.003 to 1.006); reduced liver function: lower alanine aminotransferase (HR 0.990, 95% CI: 0.986 to 0.995); renal dysfunction: cystatin C level (P for non-linearity = 0.028); oxidative stress: lower urate level (HR 0.998, 95% CI: 0.998 to 0.999); lipids dysregulation: lower LDL (HR 0.918, 95% CI: 0.872 to 0.965) and triglycerides (HR 0.924, 95% CI: 0.882 to 0.967) concentrations; insulin resistance: high glucose (HR 1.093, 95% CI: 1.045 to 1.143) and HbA1c (HR 1.017, 95% CI: 1.009 to 1.025) levels; immune dysbiosis: C−reactive protein (P for non-linearity = 5.5E-09).
In conclusion, markers of vitamin D deficiency, GH-IGF-1 axis disorders, bioactive sex hormone deficiency, reduced liver function, renal abnormalities, oxidation, insulin resistance, immune dysbiosis, and lipids dysregulation were associated with incident dementia. Our results support a contributory role of systemic disorders and diverse biological processes to onset of dementia.
Publication and source details
Original title: Serum clinical laboratory tests and risk of incident dementia: a prospective cohort study of 407,190 individuals
Xiao-Yu He; Kevin Kuo; Liu Yang; Ya-Ru Zhang; Bang-Sheng Wu; Shi-Dong Chen; Wei Cheng; Jian-Feng Feng; Jin-Tai Yu
Translational Psychiatry · 2022
© The Author(s) 2022https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.https://doi.org/10.13039/501100001809National Natural Science Foundation of China (National Science Foundation of China)82071201, 81971032Yu Jin-Tai Science and Technology Innovation 2030 Major Projects (2022ZD0211600) Shanghai Municipal Science and Technology Major Project (No.2018SHZDZX01) Research Start-up Fund of Huashan Hospital (2022QD002) Excellence 2025 Talent Cultivation Program at Fudan University (3030277001) ZHANGJIANG LAB, Tianqiao and Chrissy Chen Institute, and the State Key Laboratory of Neurobiology and Frontiers Center for Brain Science of Ministry of Education, Fudan UniversityRepository JATS snapshot; version as supplied
Source retrieved: 2026-11-11T09:34:37.529315+00:00
DOI: 10.1038/s41398-022-02082-x · PMC9352702